WJPR Citation Report New

  All Since 2021
 Citation  9186  4781
 h-index  32  25
 i10-index  256  108

Submit Article

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A CLINICAL STUDY TO EVALUATE THE EFFECT OF SHIGRUADI ASCHYOTAN (EYE DROPS) IN THE MANAGEMENT OF KAPHAJA ABHISHYANDA W.S.R. TO SEASONAL ALLERGIC CONJUNCTIVITIS

Dr. Shiwali Verma*, Prof. (Dr.) Sukhdev Singh, Prof. (Dr.) Vijayant Bhardwaj, Dr. Hardev Thakur, Dr. Pankaj

Abstract

Background: Seasonal allergic conjunctivitis (SAC) presents predominantly with ocular itching, watering, redness and burning. The clinical features described for Kaphaja Abhishyanda in Ayurveda show substantial symptom-level correspondence with SAC. Aschyotana is described as an important Kriyakalpa for ocular disorders. The present study evaluated Shigruadi Aschyotan, a topical Ayurvedic eye-drop formulation, and compared its clinical outcomes with a standard comparator eye-drop combination. Methods: This simple randomized comparative clinical study was conducted in the P.G. Department of Shalakya Tantra, R.G.G.P.G. Ayurvedic College & Hospital, Paprola. Forty patients aged 10–70 years meeting the study criteria were enrolled and allocated into two groups of 20 each. Group I received Shigruadi Aschyotan and Group II received eye drops containing phenylephrine 0.12%, naphazoline hydrochloride 0.05%, menthol 0.005% and camphor 0.01%. Treatment was for 7 days with assessments on day 3, day 7 and follow-up after completion. Thirty-two patients completed treatment (16 in each group). Subjective and objective parameters were scored and analysed using mean, SD, SE and paired Student's t-test. Results: In Group I, significant or highly significant improvement was documented for itching (65.21%), lacrimation (45.46%), discharge (50%), heaviness (57.13%), photophobia (53.85%), burning sensation (61.90%), redness/congestion (48.49%) and conjunctival hyperemia (60%); upper tarsal papillae showed 40% relief and was not statistically significant. Between-group comparison was statistically significant for itching, photophobia and burning sensation, while the remaining parameters did not show a statistically significant difference. Overall, 12.5% of Group I patients were markedly improved, 50% moderately improved and 37.5% mildly improved. Conclusion: Within the limits of this small, short-duration study, Shigruadi Aschyotan was associated with improvement in the evaluated clinical features of Kaphaja Abhishyanda/SAC, with no adverse effects reported in the dissertation. Larger studies with longer follow-up are required to establish the magnitude and durability of the observed effects.

Keywords: Kaphaja Abhishyanda; Seasonal Allergic Conjunctivitis; Shigruadi Aschyotan; Aschyotana; Kriyakalpa; Ayurveda.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More